Literature DB >> 27049216

Effect of Smoking on Joint Replacement Outcomes: Opportunities for Improvement Through Preoperative Smoking Cessation.

Erik Wright1, Tony H Tzeng, Michael Ginnetti, Mouhanad M El-Othmani, Jamal K Saleh, Jasmine Saleh, J M Lane, William M Mihalko, Khaled J Saleh.   

Abstract

Because orthopaedic surgeons focus on identifying serious potential complications, such as heart attack, stroke, and deep vein thrombosis, during the preoperative assessment, correctable factors, such as smoking, may be overlooked. Chronic exposure to nicotine has been correlated with perioperative complications that lead to worse outcomes, including decreased patient satisfaction, longer hospitalization periods, and an increased rate of hospital readmission. It has been proven that smoking is a negative risk factor for decreased bone mineral density, which leads to increased fracture risk, heightened pain, postoperative wound and bone healing complications, decreased fusion rates, and postoperative tendon and ligament healing complications. Physician-led preoperative smoking cessation programs that include, but are not limited to, pharmacotherapy plans have been shown to improve primary surgical outcomes and smoking cessation rates. Smoking has detrimental effects on specialty-specific physiology; however, there are many effective options for intervention that can improve primary outcomes.

Entities:  

Mesh:

Year:  2016        PMID: 27049216

Source DB:  PubMed          Journal:  Instr Course Lect        ISSN: 0065-6895


  2 in total

1.  A Novel In Vivo Model to Study Impaired Tissue Regeneration Mediated by Cigarette Smoke.

Authors:  Marjorie Alvarez; Myra N Chávez; Miguel Miranda; Geraldine Aedo; Miguel L Allende; José T Egaña
Journal:  Sci Rep       Date:  2018-07-19       Impact factor: 4.379

2.  Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery.

Authors:  Lauren A Beaupre; Fadi Hammal; Chrisopher DeSutter; Robert E Stiegelmar; Edward Masson; Barry A Finegan
Journal:  Tob Induc Dis       Date:  2019-02-22       Impact factor: 2.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.